Preliminary programme
5th Central European Biomedical Congress, Kraków, Poland,
May 29 – June 1, 2023, Future trends in health interventions
Venue: Auditorium Maximum, 33 Krupnicza Street, Krakow, Poland
5th Central European Biomedical Congress, Kraków, Poland,
May 29 – June 1, 2023, Future trends in health interventions
Venue: Auditorium Maximum, 33 Krupnicza Street, Krakow, Poland
Monday, May 29, 2023 | |
8.00 a.m. – 5.00 p.m. | Registration |
9.30 – 10.30 a.m. – Large Hall | Plenary lecture |
Professor Gustavo Turecki PhD, MD | |
Douglas Hospital Research Centre, McGill Group for Suicide Studies, Montreal, Quebec, Canada | |
Chair persons: Professor Marta Dziedzicka-Wasylewska, PhD; Agata Faron Górecka, PhD | |
TBA | |
10.30 – 11.00 a.m. – Exhibition Room | Coffee break |
11.00 – 12.30 p.m. – Medium Hall A | Session 1: Blood-brain barrier dysfunction in CNS disorders |
Chair persons: Professor Marta Dziedzicka-Wasylewska, PhD, Agata Faron Górecka, PhD | |
S. 01-1 | |
Professor Marta Dziedzicka-Wasylewska, PhD | |
Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland | |
Potential role of blood-brain barrier in stress resilience | |
S. 01-2 | |
Agnieszka Chocyk, PhD | |
Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland | |
Sex-specific effects of early-life stress on blood-brain barrier function and response to immune challenge in rats | |
S. 01-3 | |
Barbara Błasiak, PhD | |
Institute of Nuclear Physics Polish Academy of Sciences, Kraków, Poland | |
MRI Contrast Agents Crossing Blood-Brain Barrier | |
11.00 – 12.30 p.m. – Medium Hall B | Session 2: Mass spectrometry in medical sciences |
Chair person: Przemysław Mielczarek, PhD | |
S. 02-1 | |
Professor Giuseppe Grasso, PhD | |
University of Catania, Catania, Italy | |
TBA | |
S. 02-2 | |
Professor Vladimir Havlicek, PhD | |
Institute of Microbiology of the Czech Academy of Sciences, Prague, Czech Republic | |
Next generation infection diagnostics | |
S. 02-3 | |
Professor Anna Bodzon-Kulakowska, PhD | |
AGH University of Science and Technology, Krakow, Poland | |
TBA | |
S. 02-4 | |
Joanna Kasprzyk-Pochopień, M.Sc | |
JagiellonianUniversity, Krakow, Poland | |
TBA | |
12.30 – 1.00 p.m. – Medium Hall A, B | Sponsor presentation |
1.00 – 2.30 p.m. – Medium Hall A | Session 3: Theranostic nanocarriers for drug delivery in central nervous system disorders |
Chair persons: Professor Władysław Lasoń, PhD; Professor Piotr Warszyński, PhD | |
S. 03-1 | |
Juan Yang, PhD | |
Functional Ceramics and Nanomaterials, SINTEF, Oslo, Norway | |
Progress of Engineered nanoparticls as theranostic nanocarriers | |
S. 03-2 | |
Krzysztof Szczepanowicz , PhD | |
Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Krakow, Poland | |
Synthesis and characterization of polymer-based theranostic nanoparticles containing carnosic acid | |
S. 03-3 | |
Danuta Jantas, PhD | |
Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland | |
Biosafety and neuroprotective potency of polymer-based theranostic nanoparticles containing carnosic acid | |
S. 03-4 | |
Rugmani Meenambal, PhD | |
Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland | |
Polyacrylic acid (PAA) conjugated cerium oxide nanoparticles as efficient neuroprotectants against oxidative stress-induced cell damage in human neuronal-like cells | |
1.00 – 2.30 p.m. – Medium Hall B | Session 4: Modern approaches in immunodiagnostics and immunotherapy |
Chair person: Professor Maciej Siedlar, PhD | |
TBA | |
S. 04-1 | |
Professor Maciej Siedlar, PhD | |
Institute of Paediatrics, Jagiellonian University Medical College, Kraków, Poland | |
TBA | |
S. 04-2 | |
Proffessor Marcin Majka, PhD | |
Institute of Paediatrics, Jagiellonian University Medical College, Kraków, Poland | |
Future of cell-based therapeutics in the light of today’s developments. | |
S. 04-3 | |
Professor Gabriela Kania, PhD | |
University of Zurich, Center of Experimental Theumatology, Zurich, Switzerland | |
Tale of two tubes exploring pathological mechanisms in systemic sclerosis – focus on monocytes and macrophages | |
2.30 – 3.00 p.m. – Exhibition Room | Coffee break |
3.00 – 3.15 p.m. – Large Hall | Welcome ceremony |
Chair persons: Honorary Committee & Organizing Committee | |
3.15 – 4.15 p.m. | Inaugural lecture |
Professor Véronique Deroche-Gamonet PhD, HDR | |
Université de Bordeaux, INSERM, Neurocentre Magendie, Bordeaux, France | |
Chair person: Jan Rodriguez-Parkitna, PhD | |
TBA | |
4.15 – 4.30 p.m. | Promotion of the city of Krakow and the Maj Institute of Pharmacology Polish Academy of Sciences – Large hall |
4.30 – 5.30 p.m. – Large Hall | Music performance |
5.30 – 9.00 p.m. – Exhibition Room | Welcome party |
Tuesday, 30 May 2023 | |
9.00 – 10.30 a.m. – Medium Hall A | Session 5: The burden of neurodegenerative and psychiatric disorders: trends and future treatment |
Chair person: Professor Katarzyna Starowicz – Bubak, PhD | |
S. 05-1 | |
Professor Aron H. Lichtman, PhD | |
Virginia Commonwealth University, Richmond, VA, USA | |
TBA | |
S. 05-2 | |
Professor Danilo De Gregorio, PhD | |
Vita-Salute University and San Raffaele Scientific Institute, Milan, Italy | |
Therapeutic use of psychedelics in mental health | |
S. 05-3 | |
Iskra Pollak Dorocic | |
Stockholm University, Stockholm, Sweeden | |
Transcriptional effects of SSRI administration on brain networks | |
9.00 – 10.30 a.m. – Medium Hall B | Session 6: Sphingolipids in health and brain diseases |
Chair persons: Professor Christian P. Muller, PhD; Małgorzata Frankowska, PhD | |
S. 06-1 | |
Professor Christian P. Muller, PhD | |
Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany | |
Sphingolipids in the brain: from memory control to psychiatric disorders | |
S. 06-2 | |
Alessandro Prinetti, PhD | |
University of Milano, Italy | |
Sphingolipids orchestrating the cross-talk between different cell populations in the formation of myelin and in the repair of damaged myelin | |
S. 06-3 | |
Vittorio Maglione, PhD | |
Neuromed, Pozzilli, Italy | |
Sphingolipid alterations in Huntington’s disease: new insights into molecular mechanisms and potential therapies | |
10.30 – 11.00 a.m. – Medium Hall A, B | Sponsor presentation |
11.00 – 11.30 a.m. – Exhibition Room | Coffee break |
11.30 – 12.30 p.m. – Medium Hall | Plenary lecture |
Professor Johannes Kornhuber, PhD, MD | |
Friedrich-Alexander-Universität Erlangen-Nürnberg University Hospital, Erlangen, Germany | |
Chair person: Professor Małgorzata Filip, PhD, Professor Joanna Pera, PhD | |
TBA | |
12.30 – 1.30 p.m. – Exhibition Room | Poster session 1 |
Lunch break | |
1.30 – 3.00 p.m. – Medium Hall A | Session 7: Digital medicine – beyond diagnostics |
Chair person: Klaudia Proniewska, PhD | |
S. 07-1 | |
Klaudia Proniewska, PhD | |
Jagiellonian University Medical College, Krakow, Poland | |
TBA | |
S. 07-2 | |
Danila Potyagaylo | |
EPIQure GmbH, Nuremberg, Germany | |
Combination of 12-lead ECG with patient-specific anatomical data for personalized cardiology and electrophysiology | |
S. 07-3 | |
Peter van Dam | |
TBA | |
TBA | |
1.30 – 3.00 p.m. – Medium Hall B | Session 8: New targets, new ligands, new drugs: a novel approach for the treatment of the CNS pathologies |
Chair persons: Professor Małgorzata Kajta, PhD; Agnieszka Wnuk, PhD | |
S. 08-1 | |
Adib Zendedel, PhD | |
Institute of Neuroanatomy, Medical Faculty, RWTH Aachen University, Aachen, Germany | |
The role of microglial-derived extracellular vesicles in the pathogenesis of traumatic spinal cord injury: implication of exosomal microRNAs | |
S. 08-2 | |
Professor Joanna Śliwowska, PhD | |
Poznań University of Life Sciences, Poznań, Poland | |
Metabolic and reproductive dysfunctions associated with obesity and diabetes: From the womb to adulthood | |
S. 08-3 | |
Agnieszka Wnuk, PhD | |
Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland | |
Emerging evidence for triclocarban as a neurodevelopmental risk factor: disruption of epigenetic status and dysregulation of neurogenesis-related genes. | |
S. 08-4 | |
Professor Małgorzata Kajta, PhD | |
Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland | |
New treatment strategies against neural degenerations based on selective targeting of membrane estrogen receptors and PPARγ | |
3.00 – 3.30 p.m. – Exhibition Room | Coffee break |
3.30 – 5.00 p.m. – Medium Hall A | Session 9: Chaperons in Gaucher’s disease |
Chair person: Professor Beata Kieć-Wilk, PhD | |
S. 09-1 | |
TBA | |
TBA | |
TBA | |
S. 09-2 | |
TBA | |
TBA | |
TBA | |
S. 09-3 | |
TBA | |
TBA | |
TBA | |
3.30 – 5.00 p.m. – Medium Hall B | Session 10: Tracking brain projections and cell signaling involved in neuroadaptations triggered by cocaine, stress, or neurodegeneration |
Chair persons: Grzegorz Kreiner, PhD; Agnieszka Zelek-Molik, PhD | |
S. 10-1 | |
Rachel J. Smith, PhD | |
Texas A&M University, USA | |
Investigating the link between habitual cocaine seeking and punishment resistance in rat models of addiction | |
S. 10-2 | |
Yonatan Kupchik | |
The Institute for Medical Research Israel-Canada (IMRIC), The Hebrew University of Jerusalem, Israel | |
Multimodal differences between projections of the ventral pallidum and relevance to cocaine reward | |
S. 10-3 | |
Agnieszka Zelek-Molik, PhD | |
Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków | |
Psychosocial crowding stress affects neuroplasticity-related signalling pathways within rats’ frontal cortex in a region-dependent manner | |
S.10-4 | |
Justyna Barut, MSc | |
Maj Institute of Pharmacology, Polish Academy of Sciences, Kraków | |
Utilization of conditional single lentivirus CRISPR/Cas9 vector for efficient gene knockout generation in adult neurons in vivo and in vitro as potential new model for study prodromal phase of Parkinson’s disease |
Wednesday, 31 May 2023 | |
9.00 – 10.30 a.m. – Medium Hall A | Session 11: Medical biotechnology in disease modelling, drug research and therapy |
Chair person: Professor Józef Dulak, PhD | |
S. 11-1 | |
Professor Józef Dulak, PhD; Professor Agnieszka Łoboda, PhD | |
Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland | |
Stem cells in neurological diseases modelling and therapies: possibilities, hopes and hypes. | |
S. 11-2 | |
Florence Rage, PhD | |
Institute de Genetique Moleculaire, CNRS, Montpellier, France | |
Human NMJ: from a single chip to a Simplified Miniature Array (SMA) for drugs screening | |
S. 11-3 | |
Sifeng Chen, PhD | |
Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai, People’s Republic of China | |
The therapeutic effects of induced pluripotent stem cells and their exosomes on cardiovascular diseases | |
9.00 – 10.30 a.m. – Medium Hall B | Session 12: Novel rapid-acting antidepressants |
Chair persons: Bernadeta Szewczyk, PhD; Professor Andrzej Pilc, PhD | |
S. 12-1 | |
Professor Jeffrey M Witkin, PhD | |
University of Wisconsin – Milwaukee, USA | |
New age antidepressants create new ways to think about treatment | |
S. 12-2 | |
Professor Laura Musazzi, PhD | |
School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy | |
Molecular signature of ketamine – response/non-response in a preclinical model of depression | |
S. 12-3 | |
Professor Shigeyuki Chaki, PhD | |
Taisho Pharmaceutical, Japan | |
Ketamine-like antidepressant potential of mGlu2/3 receptor antagonists and progress of other candidates targeting the glutamatergic system |
|
10.30 – 11.00 a.m. – Medium Hall A, B | Sponsor presentation |
11.00 – 11.30 a.m. – Exhibition Room | Coffee break |
11.30 – 12.30 p.m. – Medium Hall | Plenary lecture |
Professsor Stefan Chłopicki, PhD, MD | |
Jagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland | |
Chair person: Professor Małgorzata Filip, PhD | |
TBA | |
12.30 – 1.30 p.m. – Exhibition Room | Poster session 2 |
Lunch break | |
1.30 – 3.00 p.m. – Medium Hall A | Session 13: Innovative nanocarriers and treatment modalities in antitumor therapy |
Chair person: Professor Bożena Kaczmarek, PhD | |
S. 13-1 | |
Professor Bożena Kamińska-Kaczmarek, PhD | |
Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland | |
Reinvigorating antitumor immunity in brain tumors with short peptides and siRNA-nanocarriers targeting the tumor microenvironment | |
S. 13-2 | |
Professor Ling Peng, PhD | |
Aix-Marseille University, Marseille, France | |
Modular and adaptive dendrimer nanosystems in cancer treatment | |
S. 13-3 | |
Professor Tambet Tessalu, PhD | |
University of Tartu, Tartu, Estonia | |
Targeting of nanoparticles with homing peptides | |
1.30 – 3.00 p.m. – Medium Hall B | Session 14: Duchenne muscular dystrophy and its complications – new tools and mechanisms for possible treatments |
Chair persons: Professor Agnieszka Łoboda, PhD | |
S. 14-1 | |
Maurilio Sampaolesi | |
KU Leuven, Leuven, Belgium | |
Harnessing novel 3D stem cell-based models to challenge dystrophic cardiomyopathy | |
S. 14-2 | |
Jacek Stępniewski | |
Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Kraków, Poland | |
Human induced pluripotent stem cells and gene editing for modelling of Duchenne muscular dystrophy-associated cardiomyopathy | |
S. 14-3 | |
Professor Agnieszka Łoboda, PhD | |
Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland | |
Hydrogen sulfide donors: therapeutic potential in Duchenne muscular dystrophy | |
3.00 – 3.30 p.m. – Exhibition Room | Coffee break |
3.30 – 5.00 p.m. – Medium Hall A | Session 15: Future therapies with psychodelics |
Chair person: Professor Krystyna Gołembiowska, PhD | |
S. 15-1 | |
Professor Charles Nichols, PhD | |
LSU Health Sciences Center, New Orleans, LA, US | |
A single treatment with psychedelics can produce persistent antidepressant-like effects, and changes in functional plasticity across several types of depression models in both rats and fruit flies | |
S. 15-2 | |
Urszula Kozłowska | |
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland | |
Psychedelics immunomodulatory effect on microglia and its prospect meaning for neurodegenerative diseases treatment. | |
5.00 – 6.00 p.m. – Seminar Room, Conference Room | Workshop |
CEPHARES – a new R&D division of Maj Institute of Pharmacology. Mission, opportunities, perspectives | |
TBA | |
8.00 – 11.00 p.m. | Congress dinner – Kościuszko Mound in Kraków, 1 Washington Avenue |
Thursday, 1 June 2023 | |
9.00 – 10.00 a.m. – Large Hall | Plenary lecture |
Professor Kathryn A. Cunningham, PhD | |
The University of Texas Medical Branch at Galveston, USA | |
Chair person: Professor Małgorzata Filip, PhD | |
TBA | |
10.00 – 10.30 a.m. – Exhibition Room | Coffee break |
10.30 – 12.00 a.m. – Large Hall | Session 16: Magnificent Seven: on the role of the 5-HT7R receptor in the brain |
Chair person: Monika Bijata, PhD, Professor Paweł Zajdel, PhD | |
S. 16-1 | |
Morisset-Lopez | |
Molecular Biophysics Center, The University of Orléans, INSERM, France | |
Discovery of biased ligands of 5-HT7R to illuminate the receptor biology | |
S. 16-2 | |
Professor Evgeni Ponimaskin, PhD | |
Hannover Medical School, Hannover, Germany | |
Targeting the serotonin receptor 7 (5-HT7R) ameliorates Tau pathology and memory deficits | |
S. 16-3 | |
Jakub Włodarczyk, PhD | |
Nencki Institute of Experimental Biology of Polish Academy of Science, Warsaw, Poland | |
The molecular fingerprint of stress resilience | |
12.00 -12.30 p.m. | Lunch break – Exhibition Room |
12.30 a.m. – 1.30 p.m. – Medium Hall | Plenary lecture |
Professor Stéphane Oliet, PhD | |
Bordeaux Neurocampus, University de Bordeaux, France | |
Chair person: Professor Joanna Pera, MD, PhD | |
TBA | |
1.30 – 2.45 p.m. | Session 17: |
Young scientific investigators’ session | |
75 min, Medium Hall | |
Chair person: Professor Rafał Ryguła, PhD | |
2.45 – 3.15 p.m. | Closing & Award ceremony – Medium Hall |
Chair persons: Professor Małgorzata Filip, PhD, Professor Joanna Pera, PhD |